The Delhi High Court on Wednesday asked the Delhi Government to inform it about the stocks of the medicine used for the treatment of Black Fungus.
A division bench of Justice Vipin Sanghi and Justice Jasmeet Singh asked the Delhi Government to give its response tomorrow on the stocks of the Amphotericin B drug and how they planned to distribute it.
The court's queries came after it was informed by petitioner and advocate Rakesh Malhotra that there is a shortage in the supply of medicines used to treat Black Fungus - a new issue in the ongoing Covid-19 pandemic.
The court also asked how there can suddenly be a shortage in supply when the drug is being manufactured locally and remarked that this cannot be a case of artificial shortage.
The Court has listed the matter for further hearing tomorrow.
Senior Advocate Rahul Mehra, appearing for the Delhi Government said that this issue is part of amicus note. It has been requisitioned from the Centre and there is a committee which meets twice a day, submitted to Rahul Mehra and said that he will come back tomorrow.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU